247 related articles for article (PubMed ID: 10713690)
1. Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation.
Deng CX; Scott F
Oncogene; 2000 Feb; 19(8):1059-64. PubMed ID: 10713690
[TBL] [Abstract][Full Text] [Related]
2. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation.
Xu X; Wagner KU; Larson D; Weaver Z; Li C; Ried T; Hennighausen L; Wynshaw-Boris A; Deng CX
Nat Genet; 1999 May; 22(1):37-43. PubMed ID: 10319859
[TBL] [Abstract][Full Text] [Related]
3. Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis.
Xu X; Qiao W; Linke SP; Cao L; Li WM; Furth PA; Harris CC; Deng CX
Nat Genet; 2001 Jul; 28(3):266-71. PubMed ID: 11431698
[TBL] [Abstract][Full Text] [Related]
4. The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans.
Moynahan ME
Oncogene; 2002 Dec; 21(58):8994-9007. PubMed ID: 12483515
[TBL] [Abstract][Full Text] [Related]
5. Mammary tumor formation in p53- and BRCA1-deficient mice.
Cressman VL; Backlund DC; Hicks EM; Gowen LC; Godfrey V; Koller BH
Cell Growth Differ; 1999 Jan; 10(1):1-10. PubMed ID: 9950212
[TBL] [Abstract][Full Text] [Related]
6. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer.
Weaver Z; Montagna C; Xu X; Howard T; Gadina M; Brodie SG; Deng CX; Ried T
Oncogene; 2002 Aug; 21(33):5097-107. PubMed ID: 12140760
[TBL] [Abstract][Full Text] [Related]
7. Roles of BRCA1 and its interacting proteins.
Deng CX; Brodie SG
Bioessays; 2000 Aug; 22(8):728-37. PubMed ID: 10918303
[TBL] [Abstract][Full Text] [Related]
8. Retroviral transduction of splice variant Brca1-Delta11 or mutant Brca1-W1777Stop causes mouse epithelial mammary atypical duct hyperplasia.
Bachelier R; Vincent A; Mathevet P; Magdinier F; Lenoir GM; Frappart L
Virchows Arch; 2002 Mar; 440(3):261-6. PubMed ID: 11889595
[TBL] [Abstract][Full Text] [Related]
9. A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development.
Jerry DJ; Kittrell FS; Kuperwasser C; Laucirica R; Dickinson ES; Bonilla PJ; Butel JS; Medina D
Oncogene; 2000 Feb; 19(8):1052-8. PubMed ID: 10713689
[TBL] [Abstract][Full Text] [Related]
10. BRCA1 carries tumor suppressor activity distinct from that of p53 and p21.
Randrianarison V; Marot D; Foray N; Cabannes J; Méret V; Connault E; Vitrat N; Opolon P; Perricaudet M; Feunteun J
Cancer Gene Ther; 2001 Oct; 8(10):759-70. PubMed ID: 11687899
[TBL] [Abstract][Full Text] [Related]
11. Tumorigenesis as a consequence of genetic instability in Brca1 mutant mice.
Deng CX
Mutat Res; 2001 Jun; 477(1-2):183-9. PubMed ID: 11376699
[TBL] [Abstract][Full Text] [Related]
12. Atm heterozygosity cooperates with loss of Brca1 to increase the severity of mammary gland cancer and reduce ductal branching.
Bowen TJ; Yakushiji H; Montagna C; Jain S; Ried T; Wynshaw-Boris A
Cancer Res; 2005 Oct; 65(19):8736-46. PubMed ID: 16204043
[TBL] [Abstract][Full Text] [Related]
13. A targeted disruption of the murine Brca1 gene causes gamma-irradiation hypersensitivity and genetic instability.
Shen SX; Weaver Z; Xu X; Li C; Weinstein M; Chen L; Guan XY; Ried T; Deng CX
Oncogene; 1998 Dec; 17(24):3115-24. PubMed ID: 9872327
[TBL] [Abstract][Full Text] [Related]
14. Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice.
Brodie SG; Xu X; Qiao W; Li WM; Cao L; Deng CX
Oncogene; 2001 Nov; 20(51):7514-23. PubMed ID: 11709723
[TBL] [Abstract][Full Text] [Related]
15. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
[TBL] [Abstract][Full Text] [Related]
16. Further evidence for BRCA1 communication with the inactive X chromosome.
Silver DP; Dimitrov SD; Feunteun J; Gelman R; Drapkin R; Lu SD; Shestakova E; Velmurugan S; Denunzio N; Dragomir S; Mar J; Liu X; Rottenberg S; Jonkers J; Ganesan S; Livingston DM
Cell; 2007 Mar; 128(5):991-1002. PubMed ID: 17350581
[TBL] [Abstract][Full Text] [Related]
17. Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene.
Robinson GW; Wagner KU; Hennighausen L
Oncogene; 2001 Oct; 20(48):7115-9. PubMed ID: 11704837
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of a novel BRCA1-null ovarian cancer cell line in response to ionizing radiation.
DelloRusso C; Welcsh PL; Wang W; Garcia RL; King MC; Swisher EM
Mol Cancer Res; 2007 Jan; 5(1):35-45. PubMed ID: 17259345
[TBL] [Abstract][Full Text] [Related]
19. BRCA1 gene in breast cancer.
Rosen EM; Fan S; Pestell RG; Goldberg ID
J Cell Physiol; 2003 Jul; 196(1):19-41. PubMed ID: 12767038
[TBL] [Abstract][Full Text] [Related]
20. Impact of ionizing radiation and genetic background on mammary tumorigenesis in p53-deficient mice.
Backlund MG; Trasti SL; Backlund DC; Cressman VL; Godfrey V; Koller BH
Cancer Res; 2001 Sep; 61(17):6577-82. PubMed ID: 11522657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
